Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Ganciclovir%22&type=Subject&filter%5B%5D=collection%3ACTG
/vufind/Search/Results?lookfor=%22Ganciclovir%22&type=Subject&filter%5B%5D=collection%3ACTG
Search /vufind/Search2/Results?lookfor=%22Ganciclovir%22&type=Subject&filter%5B%5D=collection%3ACTG
PubPharm (18)
1
Cytomegalo Virus infection reactivation in Bone Marrow Transplant patients with use of Ganciclovir. : A study of the kinetics of CMV viremia in patients undergoing bone marrow transplantation andidentification of cutoffs for initiation of ganciclovir therapy in patients who show reactivation of CMVinfection - NA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
2
Cytomegalo Virus infection reactivation in Bone Marrow Transplant patients with use of Ganciclovir. : A study of the kinetics of CMV viremia in patients undergoing bone marrow transplantation andidentification of cutoffs for initiation of ganciclovir therapy in patients who show reactivation of CMVinfection - NA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
3
UN ESTUDIO ALEATORIZADO, DOBLE CIEGO PARA EVALUAR LA EFICACIA Y SEGURIDAD DEL USO PROFILÁCTICO DE MARIBAVIR FRENTE A GANCICLOVIR ORAL PARA LA PREVENCIÓN DE LA ENFERMEDAD POR CITOMEGALOVIRUS EN RECEPTORES DE TRASPLANTES ORTOTÓPICOS DE HÍGADOA RANDOMIZED, DOUBLE-BLIND STUDY TO ASSESS THE EFFICACY AND SAFETY OF PROPHYLACTIC USE OF MARIBAVIR VERSUS ORAL GANCICLOVIR FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE IN RECIPIENTS OF ORTHOTOPIC LIVER TRANSPLANTS : UN ESTUDIO ALEATORIZADO, DOBLE CIEGO PARA EVALUAR LA EFICACIA Y SEGURIDAD DEL USO PROFILÁCTICO DE MARIBAVIR FRENTE A GANCICLOVIR ORAL PARA LA PREVENCIÓN DE LA ENFERMEDAD POR CITOMEGALOVIRUS EN RECEPTORES DE TRASPLANTES ORTOTÓPICOS DE HÍGADOA RANDOMIZED, DOUBLE-BLIND STUDY TO ASSESS THE EFFICACY AND SAFETY OF PROPHYLACTIC USE OF MARIBAVIR VERSUS ORAL GANCICLOVIR FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE IN RECIPIENTS OF ORTHOTOPIC LIVER TRANSPLANTS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
4
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF PROPHYLACTIC USE OF MARIBAVIR VERSUS ORAL GANCICLOVIR FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE IN RECEIPIENTS OF ORTHOTOPIC LIVER TRANSPLANTS : A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF PROPHYLACTIC USE OF MARIBAVIR VERSUS ORAL GANCICLOVIR FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE IN RECEIPIENTS OF ORTHOTOPIC LIVER TRANSPLANTS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
5
UN ESTUDIO ALEATORIZADO, DOBLE CIEGO PARA EVALUAR LA EFICACIA Y SEGURIDAD DEL USO PROFILÁCTICO DE MARIBAVIR FRENTE A GANCICLOVIR ORAL PARA LA PREVENCIÓN DE LA ENFERMEDAD POR CITOMEGALOVIRUS EN RECEPTORES DE TRASPLANTES ORTOTÓPICOS DE HÍGADOA RANDOMIZED, DOUBLE-BLIND STUDY TO ASSESS THE EFFICACY AND SAFETY OF PROPHYLACTIC USE OF MARIBAVIR VERSUS ORAL GANCICLOVIR FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE IN RECIPIENTS OF ORTHOTOPIC LIVER TRANSPLANTS : UN ESTUDIO ALEATORIZADO, DOBLE CIEGO PARA EVALUAR LA EFICACIA Y SEGURIDAD DEL USO PROFILÁCTICO DE MARIBAVIR FRENTE A GANCICLOVIR ORAL PARA LA PREVENCIÓN DE LA ENFERMEDAD POR CITOMEGALOVIRUS EN RECEPTORES DE TRASPLANTES ORTOTÓPICOS DE HÍGADOA RANDOMIZED, DOUBLE-BLIND STUDY TO ASSESS THE EFFICACY AND SAFETY OF PROPHYLACTIC USE OF MARIBAVIR VERSUS ORAL GANCICLOVIR FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE IN RECIPIENTS OF ORTHOTOPIC LIVER TRANSPLANTS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
6
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF PROPHYLACTIC USE OF MARIBAVIR VERSUS ORAL GANCICLOVIR FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE IN RECEIPIENTS OF ORTHOTOPIC LIVER TRANSPLANTS : A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF PROPHYLACTIC USE OF MARIBAVIR VERSUS ORAL GANCICLOVIR FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE IN RECEIPIENTS OF ORTHOTOPIC LIVER TRANSPLANTS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
7
Multicenter clinical trial to evaluate the efficacy of a preventive strategy against CMV infection in heart transplant patients, based on T cells responses. : The proposed study is a phase IV, randomized, controlled, multicenter and open clinical trial, with two parallel groups, to evaluate the effectiveness of a preventive strategy against CMV infection in heart transplant patients with positive serology against CMV based on T cells responses to IE-1 and pp65 CMV antigens, determined by ELISPOT IFN-? assay - ELISPOT-TC
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
8
Multicenter clinical trial to evaluate the efficacy of a preventive strategy against CMV infection in heart transplant patients, based on T cells responses. : The proposed study is a phase IV, randomized, controlled, multicenter and open clinical trial, with two parallel groups, to evaluate the effectiveness of a preventive strategy against CMV infection in heart transplant patients with positive serology against CMV based on T cells responses to IE-1 and pp65 CMV antigens, determined by ELISPOT IFN-? assay - ELISPOT-TC
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
9
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF PROPHYLACTIC USE OF MARIBAVIR VERSUS ORAL GANCICLOVIR FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE IN RECEIPIENTS OF ORTHOTOPIC LIVER TRANSPLANTS : A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF PROPHYLACTIC USE OF MARIBAVIR VERSUS ORAL GANCICLOVIR FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE IN RECEIPIENTS OF ORTHOTOPIC LIVER TRANSPLANTS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2013
Wird geladen...
10
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF PROPHYLACTIC USE OF MARIBAVIR VERSUS ORAL GANCICLOVIR FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE IN RECEIPIENTS OF ORTHOTOPIC LIVER TRANSPLANTS : A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF PROPHYLACTIC USE OF MARIBAVIR VERSUS ORAL GANCICLOVIR FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE IN RECEIPIENTS OF ORTHOTOPIC LIVER TRANSPLANTS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2013
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
18
Aufsätze
18
E-Artikel
18
E-Ressourcen
Zeitschriftentitel
18
WHO International Clinical Trials Registry Plat...
Thema
18
610
18
Study Type: Interventional
14
Recruitment Status: Not yet recruiting
12
Medical Condition: Main purpose is to assess th...
4
Phase: Phase 3
2
Medical Condition: Evaluar la eficacia y seguri...
2
Medical Condition: Health Condition 1: null- Pa...
2
Medical Condition: We will investigate the bene...
2
Phase: Phase 4
2
Recruitment Status: Authorised-recruitment may ...
2
Recruitment Status: Recruiting
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
8
2020-
10
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
18
Englisch
Haven't found what you're looking for?
Wird geladen...